Human Albumin Fragments Nanoparticles as PTX Carrier for Improved Anti-cancer Efficacy.

Ge, Liang; You, Xinru; Huang, Jun; Chen, Yuejian; Chen, Li; Zhu, Ying; Zhang, Yuan; Liu, Xiqiang; Wu, Jun; Hai, Qian

Ge, Liang; You, Xinru; Huang, Jun; Chen, Yuejian; Chen, Li; Zhu, Ying; Zhang, Yuan; Liu, Xiqiang; Wu, Jun; Hai, Qian.

Afiliación

Ge L; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
You X; School of Pharmacy, Xinjiang Medical University, Ürümqi, China.
Huang J; Key Laboratory of Sensing Technology and Biomedical Instruments of Guangdong Province, School of Biomedical Engineering, Sun Yat-sen University, Guangzhou, China.
Chen Y; Key Laboratory of Sensing Technology and Biomedical Instruments of Guangdong Province, School of Biomedical Engineering, Sun Yat-sen University, Guangzhou, China.
Chen L; Nanjing iPharma Technology, Co., Ltd., Nanjing, China.
Zhu Y; School of Pharmacy, Xinjiang Medical University, Ürümqi, China.
Zhang Y; State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Liu X; Department of Orthopedics, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Wu J; Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Hai Q; Key Laboratory of Sensing Technology and Biomedical Instruments of Guangdong Province, School of Biomedical Engineering, Sun Yat-sen University, Guangzhou, China.

Front Pharmacol ; 9: 582, 2018.

Article en En | MEDLINE | ID: mdl-29946256

Palabras clave

anticancer; drug delivery; human serum albumin fragments; nanoparticle; paclitaxel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google